APA (7th ed.) Citation

GC, B., KE, C., M, W., RJ, G., K, H., CA, P., . . . M, S. (2017). Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Clinical pharmacology and therapeutics, 102(2), 213. https://doi.org/10.1002/cpt.598

Chicago Style (17th ed.) Citation

GC, Bell, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron." Clinical Pharmacology and Therapeutics 102, no. 2 (2017): 213. https://doi.org/10.1002/cpt.598.

MLA (9th ed.) Citation

GC, Bell, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron." Clinical Pharmacology and Therapeutics, vol. 102, no. 2, 2017, p. 213, https://doi.org/10.1002/cpt.598.